Air pollution and plasma amyloid beta in a cohort of older adults: Evidence from the Ginkgo Evaluation of Memory Study

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

(2022) Emma Nichols et al.   Lancet Public Health

Air pollution and dementia in older adults in the Ginkgo Evaluation of Memory Study

(2022) Erin O. Semmens et al.   Alzheimers & Dementia

A Systematic Review and Meta-Analysis of Cerebrospinal Fluid Amyloid and Tau Levels Identifies Mild Cognitive Impairment Patients Progressing to Alzheimer’s Disease

(2022) Yunxing Ma et al.   Biomedicines

Fine Particulate Matter and Markers of Alzheimer’s Disease Neuropathology at Autopsy in a Community-Based Cohort

(2021) Rachel M. Shaffer et al.   JOURNAL OF ALZHEIMERS DISEASE

Validation of LexisNexis® Accurint® in the Georgia Cancer Registry’s Cancer Recurrence and Information Surveillance Program

(2021) Kirsten M. Woolpert et al.   EPIDEMIOLOGY

The Effects of Chronic Exposure to Ambient Traffic-Related Air Pollution on Alzheimer’s Disease Phenotypes in Wildtype and Genetically Predisposed Male and Female Rats

(2021) Kelley T. Patten et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Biomarkers for neurodegenerative diseases

(2021) Oskar Hansson   NATURE MEDICINE

Associations between air pollution and biomarkers of Alzheimer’s disease in cognitively unimpaired individuals

(2021) Silvia Alemany et al.   ENVIRONMENT INTERNATIONAL

Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer’s Disease

(2020) Gurjit Kaur Bhatti et al.   Frontiers in Aging Neuroscience

Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive Impairment

(2020) Leonardo Iaccarino et al.   JAMA Neurology

Amyloid-β as a Blood Biomarker for Alzheimer’s Disease: A Review of Recent Literature

(2019) Xiaoni Wang et al.   JOURNAL OF ALZHEIMERS DISEASE

Prevention of dementia by targeting risk factors

(2018) Mika Kivimäki et al.   LANCET

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

(2018) Akinori Nakamura et al.   NATURE

Meta-Analysis of Plasma Amyloid-β levels in Alzheimer's Disease

(2018) Fei Song et al.   JOURNAL OF ALZHEIMERS DISEASE

Amyloid-Beta (1-40) Peptide and Subclinical Cardiovascular Disease

(2018) Kimon Stamatelopoulos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Non-Phosphorylated Tau in Cerebrospinal Fluid is a Marker of Alzheimer’s Disease Continuum in Young Urbanites Exposed to Air Pollution

(2018) Lilian Calderón-Garcidueñas et al.   JOURNAL OF ALZHEIMERS DISEASE

Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study

(2017) Kirsten E. Peters et al.   JOURNAL OF ALZHEIMERS DISEASE

Historical Prediction Modeling Approach for Estimating Long-Term Concentrations of PM2.5 in Cohort Studies before the 1999 Implementation of Widespread Monitoring

(2016) Sun-Young Kim et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Satellite-Based NO2 and Model Validation in a National Prediction Model Based on Universal Kriging and Land-Use Regression

(2016) Michael T. Young et al.   ENVIRONMENTAL SCIENCE & TECHNOLOGY

Association of Plasma Aβ40 Peptides, But Not Aβ42, with Coronary Artery Disease and Diabetes Mellitus

(2016) Benjamin Roeben et al.   JOURNAL OF ALZHEIMERS DISEASE

Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer’s and Parkinson’s Diseases in Young Mexico City Residents

(2016) Lilian Calderón-Garcidueñas et al.   JOURNAL OF ALZHEIMERS DISEASE

Spontaneous Reversion of Mild Cognitive Impairment to Normal Cognition: A Systematic Review of Literature and Meta-Analysis

(2016) Marco Canevelli et al.   Journal of the American Medical Directors Association

Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects

(2015) Jon B. Toledo et al.   BRAIN

Cerebrospinal fluid tau and amyloid-β1-42in patients with dementia

(2015) Tobias Skillbäck et al.   BRAIN

Prevalence of Amyloid PET Positivity in Dementia Syndromes

(2015) Rik Ossenkoppele et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

(2015) Willemijn J. Jansen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Environmental factors in cardiovascular disease

(2015) Kristen E. Cosselman et al.   Nature Reviews Cardiology

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study

(2015) Julien Dumurgier et al.   Alzheimers Research & Therapy

Longitudinal Associations Between Neighborhood Physical and Social Environments and Incident Type 2 Diabetes Mellitus

(2015) Paul J. Christine et al.   JAMA Internal Medicine

A Pilot Study to Assess Effects of Long-Term Inhalation of Airborne Particulate Matter on Early Alzheimer-Like Changes in the Mouse Brain

(2015) Dhaval P. Bhatt et al.   PLoS One

β-amyloid Peptides and Amyloid Plaques in Alzheimer’s Disease

(2014) Gunnar K. Gouras et al.   Neurotherapeutics

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

Midlife Blood Pressure, Plasma β-Amyloid, and the Risk for Alzheimer Disease

(2012) Nilay S. Shah et al.   HYPERTENSION

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

(2012) Randall J. Bateman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Particulate Matter Air Pollution and Cardiovascular Disease

(2010) Robert D. Brook et al.   CIRCULATION

Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study

(2009) Beth E. Snitz et al.   AGING & MENTAL HEALTH

Cystatin C: a potential target for Alzheimer’s treatment

(2008) Efrat Levy   Expert Review of Neurotherapeutics

Ginkgo biloba for Prevention of DementiaA Randomized Controlled Trial

(2008) Steven T. DeKosky   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-term Air Pollution Exposure Is Associated with Neuroinflammation, an Altered Innate Immune Response, Disruption of the Blood-Brain Barrier, Ultrafine Particulate Deposition, and Accumulation of Amyloid β-42 and α-Synuclein in Children and Young Adults

(2008) Lilian Calderón-Garcidueñas et al.   TOXICOLOGIC PATHOLOGY